Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease
- PMID: 22081615
- DOI: 10.1080/07315724.2011.10719972
Metabolic syndrome in childhood from impaired carbohydrate metabolism to nonalcoholic fatty liver disease
Abstract
Compelling evidence supports the concept that nonalcoholic fatty liver disease (NAFLD) represents the hepatic component of metabolic syndrome (MetS). Intrahepatic fat seems to predict more strongly than does visceral adiposity an individual's cardiovascular risk and the likelihood that metabolic abnormalities are present in youth. Young individuals with fatty liver are more insulin resistant and present with a higher prevalence of metabolic abnormalities than do individuals without intrahepatic fat accumulation. They also present with a certain endothelial dysfunction and greater carotid intima-media thickness. Conversely, youth with MetS seem to have an increased risk of developing liver inflammation, a condition termed nonalcoholic steatohepatitis (NASH), and fibrosis. In the context of MetS, the liver is central in that it can drive both hepatic and systemic insulin resistance, trigger low-grade inflammation, and promote atherogenic processes. In the context of MetS, NAFLD and altered carbohydrate metabolism track from childhood to adulthood. Thus, prevention, recognition, and effective treatment of these two abnormalities may limit the burden of morbidity and mortality associated with obesity and may delay onset of cardiovascular disease in early adulthood. The present review aims at systematically presenting evidence of the critical interplay of fatty liver and altered glucose metabolism in youth. It attempts to provide pathogenetic explanations for such an association and the rationale for its treatment, with particular regard to nutritional interventions. Key teaching points: Overweight and obese youth should be screened for fatty liver disease once after puberty by liver function tests and ultrasonography. Screening for fatty liver should be accurately performed in young patients with features of metabolic syndrome. Obese patients with fatty liver are at increased risk for altered glucose metabolism, thus they should undergo an oral glucose tolerance test. A nutritional and behavioral intervention aimed at achieving a permanent change of the lifestyle in patients and their parents is recommended.
Similar articles
-
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.World J Gastroenterol. 2011 Jul 14;17(26):3082-91. doi: 10.3748/wjg.v17.i26.3082. World J Gastroenterol. 2011. PMID: 21912450 Free PMC article. Review.
-
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.Am J Gastroenterol. 2012 Dec;107(12):1852-8. doi: 10.1038/ajg.2012.314. Epub 2012 Oct 2. Am J Gastroenterol. 2012. PMID: 23032980
-
Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?World J Gastroenterol. 2011 Feb 14;17(6):735-42. doi: 10.3748/wjg.v17.i6.735. World J Gastroenterol. 2011. PMID: 21390143 Free PMC article.
-
The metabolic syndrome and nonalcoholic fatty liver disease in children.Curr Opin Pediatr. 2009 Aug;21(4):529-35. doi: 10.1097/MOP.0b013e32832cb16f. Curr Opin Pediatr. 2009. PMID: 19444112 Free PMC article. Review.
-
Insulin resistance in nonalcoholic fatty liver disease.Curr Pharm Des. 2010 Jun;16(17):1941-51. doi: 10.2174/138161210791208875. Curr Pharm Des. 2010. PMID: 20370677 Review.
Cited by
-
Delayed intervention with a novel SGLT2 inhibitor NGI001 suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice.Br J Pharmacol. 2020 Jan;177(2):239-253. doi: 10.1111/bph.14859. Epub 2019 Nov 12. Br J Pharmacol. 2020. PMID: 31497874 Free PMC article.
-
Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.Int J Environ Res Public Health. 2021 Jan 20;18(3):857. doi: 10.3390/ijerph18030857. Int J Environ Res Public Health. 2021. PMID: 33498329 Free PMC article.
-
Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study.Acta Diabetol. 2021 Aug;58(8):1009-1022. doi: 10.1007/s00592-020-01669-4. Epub 2021 Mar 22. Acta Diabetol. 2021. PMID: 33754165
-
Bone marrow adipose tissue content in Latino adolescents with prediabetes and obesity.Obesity (Silver Spring). 2021 Dec;29(12):2100-2107. doi: 10.1002/oby.23279. Epub 2021 Sep 28. Obesity (Silver Spring). 2021. PMID: 34582099 Free PMC article.
-
Chromatin Modifications Associated With Diabetes and Obesity.Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1557-61. doi: 10.1161/ATVBAHA.115.305041. Epub 2015 Jun 4. Arterioscler Thromb Vasc Biol. 2015. PMID: 26044585 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical